Skip to main content
Fig. 2 | Journal of Inflammation

Fig. 2

From: IL-35 alleviates inflammation progression in a rat model of diabetic neuropathic pain via inhibition of JNK signaling

Fig. 2

A possible mechanism for IL-35-mediated anti-inflammatory effect. The protein levels of IL-35 (a), JNK and p-JNK (b) using western blotting, and the mRNA expression levels of IL-1β (c), IL-6 (d) and TNF-α (e) and IL-10 (f) determined by qRT-PCR in the groups of Control, DNP, DNP + vehicle, SP, IL-35 and IL-35 + Ani. *P < 0.05 vs. the control group; #P < 0.05 vs. the DNP + vehicle group; $P < 0.05 vs. the IL-35 group. n = 6 per group

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us